DOLPHINS. In collaboration with the US Navy Marine Mammal Program, we are evaluating the microbial dynamics mediating the efficacy of fecal microbiome transplants for treatment of irritable bowel syndrome in common bottlenose dolphins (Tursiops truncatus). The underlying cause(s) of IBS in dolphins are not well known, and affected individuals may experience chronic symptoms that negatively impact quality of life and task performance. This multi-phase project is currently underway with completion anticipated in 2023. |
|